{"id":"W2804378061","doi":"10.1158/1078-0432.ccr-18-0613","title":"Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech","keywords":"Fulvestrant; Breast cancer; Cancer; Medicine; Internal medicine; Oncology; Hormone receptor; Phases of clinical research; Hormone; Metastatic breast cancer; Toxicity; Estrogen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001335089,0.0003111693,0.0009033605,0.0004294661,0.0001590629,0.00001578807,0.0002822147,0.0001469969,0.0003376637],"category_scores_gemma":[0.0002178041,0.0002290132,0.00005174753,0.002015553,0.001447278,0.0003595022,0.0001329842,0.001211461,0.000006302949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007832727,"about_ca_system_score_gemma":0.0008360128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004678381,"about_ca_topic_score_gemma":0.009776035,"domain_scores_codex":[0.9952964,0.0006440309,0.0009488699,0.0008940346,0.001482592,0.0007340545],"domain_scores_gemma":[0.9960667,0.0005037224,0.0003024779,0.0005637462,0.002274608,0.0002887469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1531529,0.03111556,0.628473,0.00008868419,0.0003267944,0.00004108477,0.004075808,0.00006818168,0.0006013197,0.00001706926,0.0001437457,0.1818958],"study_design_scores_gemma":[0.0948814,0.0651626,0.8350728,0.001149633,0.00004825934,0.000002055559,0.002118821,0.00004637412,0.001011931,0.00005936733,0.000191225,0.0002555989],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946063,0.0002791872,0.00002665829,0.001259566,0.0001076703,0.003302324,0.000268572,0.00002727164,0.0001224472],"genre_scores_gemma":[0.9980767,0.0002341516,0.0004050235,0.0001190591,0.0001832829,0.0007289858,0.00003876513,0.00007035705,0.0001436378],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2065997,"threshold_uncertainty_score":0.9338889,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06313931023451126,"score_gpt":0.4699763740301713,"score_spread":0.40683706379566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}